Literature DB >> 9344843

Erythropoietin and IL-3 induce tyrosine phosphorylation of CrkL and its association with Shc, SHP-2, and Cbl in hematopoietic cells.

H Chin1, T Saito, A Arai, K Yamamoto, R Kamiyama, N Miyasaka, O Miura.   

Abstract

The present study demonstrates that erythropoietin (Epo) and IL-3 induce tyrosine phosphorylation of the SH2/SH3-containing adapter protein CrkL and its transient association with tyrosine-phosphorylated SHP-2, Shc, and Cbl in a murine IL-3-dependent cell line, 32D, expressing the Epo receptor (EpoR). In these cells, CrkL was constitutively complexed with the guanine nucleotide exchange factor C3G, which was found to coimmunoprecipitate with Shc from Epo- or IL-3-stimulated cells. Studies using cells expressing mutant EpoRs showed that the Epo-induced tyrosine phosphorylation of CrkL is dependent on the membrane-proximal EpoR cytoplasmic region involved in the activation of Jak2 as well as the C-terminal 145 amino acid region which is required for tyrosine phosphorylation of SHP-2 and Shc. It was further revealed that CrkL is recruited to the tyrosine-phosphorylated EpoR, most likely through its interaction with tyrosine-phosphorylated Shc and SHP-2. These results suggest that CrkL is involved in the signaling pathways from the receptors for Epo and IL-3, most likely by modulating the activity of the Ras family GTPases through its interaction with C3G. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344843     DOI: 10.1006/bbrc.1997.7480

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.

Authors:  Z Z Chong; K Maiese
Journal:  Histol Histopathol       Date:  2007-11       Impact factor: 2.303

2.  Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling.

Authors:  Matthew A Held; Emily Greenfest-Allen; Su Su; Christian J Stoeckert; Matthew P Stokes; Don M Wojchowski
Journal:  Cell Signal       Date:  2020-02-03       Impact factor: 4.315

3.  Core erythropoietin receptor signals for late erythroblast development.

Authors:  Madhu P Menon; Jing Fang; Don M Wojchowski
Journal:  Blood       Date:  2005-12-06       Impact factor: 22.113

4.  STAT5 activation is critical for the transformation mediated by myeloproliferative disorder-associated JAK2 V617F mutant.

Authors:  Megumi Funakoshi-Tago; Kenji Tago; Miyuki Abe; Yoshiko Sonoda; Tadashi Kasahara
Journal:  J Biol Chem       Date:  2009-12-22       Impact factor: 5.157

5.  Gab adapter proteins as therapeutic targets for hematologic disease.

Authors:  Sheetal Verma; Tamisha Vaughan; Kevin D Bunting
Journal:  Adv Hematol       Date:  2011-12-14

6.  C3G Regulates STAT3, ERK, Adhesion Signaling, and Is Essential for Differentiation of Embryonic Stem Cells.

Authors:  Vijay V Vishnu; Bh Muralikrishna; Archana Verma; Sanjeev Chavan Nayak; Divya Tej Sowpati; Vegesna Radha; P Chandra Shekar
Journal:  Stem Cell Rev Rep       Date:  2021-02-23       Impact factor: 6.692

7.  Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndrome.

Authors:  Hannah Steeb; Jordan M Ramsey; Paul C Guest; Pawel Stocki; Jason D Cooper; Hassan Rahmoune; Erin Ingudomnukul; Bonnie Auyeung; Liliana Ruta; Simon Baron-Cohen; Sabine Bahn
Journal:  Mol Autism       Date:  2014-01-27       Impact factor: 7.509

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.